$1.2 Billion is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNST | MONSTER BEVERAGE CORP NEW | $472,773,227 | +16.8% | 4,656,488 | 0.0% | 39.54% | +28.0% | |
| STAA | Buy | STAAR SURGICAL CO | $426,330,800 | -29.7% | 8,783,082 | +2.2% | 35.66% | -22.9% |
| AXON | AXON ENTERPRISE INC | $126,117,088 | +43.4% | 760,062 | 0.0% | 10.55% | +57.1% | |
| IWM | ISHARES TRrussell 2000 etf | $120,308,400 | +5.7% | 690,000 | 0.0% | 10.06% | +15.9% | |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $40,874,517 | +3.5% | 34,935,485 | 0.0% | 3.42% | +13.5% | |
| OCX | ONCOCYTE CORP | $7,494,201 | -56.0% | 23,353,697 | 0.0% | 0.63% | -51.8% | |
| AGE | AGEX THERAPEUTICS INC | $1,654,130 | -1.7% | 2,997,156 | 0.0% | 0.14% | +7.8% | |
| BTRS | Exit | BTRS HOLDINGS INC | $0 | – | -4,229,652 | -100.0% | -2.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
| ISHARES TR | 33 | Q3 2023 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
| AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-14 |
| 4 | 2023-11-09 |
| 4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.